Metastatic Colorectal Cancers Completed Phase 1 / 2 Trials for Encorafenib (DB11718)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02278133Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway MutationsTreatment